Premium
High prevalence of alcohol use disorders in patients with inflammatory skin diseases
Author(s) -
AlJefri K.,
NewburyBirch D.,
Muirhead C.R.,
Gilvarry E.,
AraújoSoares V.,
Reynolds N.J.,
Kaner E.,
Hampton P.J.
Publication year - 2017
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.15497
Subject(s) - medicine , psoriasis , odds ratio , population , dermatology life quality index , systemic lupus erythematosus , outpatient clinic , dermatology , disease , environmental health
Summary Background There is a known association between psoriasis and heavy alcohol consumption. The association between heavy alcohol consumption and other inflammatory skin diseases remains to be defined. Objectives To examine the prevalence of heavy drinking using the Alcohol Use Disorders Identification Test ( AUDIT ) in patients with inflammatory skin disease. Methods We conducted an observational cross‐sectional study in a single hospital outpatient department. We recruited 609 patients with either psoriasis, eczema, cutaneous lupus or other inflammatory disorders, and a reference population with skin lesions. Primary outcome was the proportion of patients in each group with an alcohol use disorder ( AUD ). Results The observed prevalence of AUD was 30·6% in patients with psoriasis, 33·3% in those with eczema, 12·3% in those with cutaneous lupus, 21·8% in those with other inflammatory disease and 14·3% in those with non‐inflammatory disease. Odds ratios ( OR ) for AUD in patients in the inflammatory groups compared with those in the noninflammatory groups, adjusted for age and sex, were as follows: psoriasis 1·65 [95% confidence interval ( CI ) 0·86–3·17], eczema 2·00 (95% CI 1·03–3·85), lupus 1·03 (95% CI 0·39–2·71), other inflammatory disease 1·32 (95% CI 0·68–2·56). OR s were reduced if also adjusted for Dermatology Life Quality Index ( DLQI ). The prevalence of DLQI ≥ 11 was 31·1% for psoriasis, 43·7% for eczema, 17·5% for cutaneous lupus, 17·2% for other inflammatory disease and 2·8% for noninflammatory disease. Conclusions Patients with eczema attending a hospital clinic have been shown to have high levels of AUD of a similar level to patients with psoriasis and higher than patients with noninflammatory skin diseases.